Tetsu Watanabe
Director/Board Member chez TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
Profil
Tetsu Watanabe currently works at Taisho Pharmaceutical Co., Ltd., as Director & Managing Executive Officer from 2016 and Taisho Pharmaceutical Holdings Co., Ltd., as Director & Head-Corporate Communications from 2015.
Postes actifs de Tetsu Watanabe
| Sociétés | Poste | Début |
|---|---|---|
| TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. | Director/Board Member | 01/06/2015 |
Taisho Pharmaceutical Co., Ltd.
 Taisho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan. | Director/Board Member | 01/06/2015 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Taisho Pharmaceutical Co., Ltd.
Taisho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan. | Health Technology |
